AI Symptom Checker for EDs

Commercial and four-phase research collaboration opportunity with AI-based solution for clinical triage and self-assessment that has run over 4,000,000 symptom assessments worldwide. d

Solution is the only scientifically-validated solution being commercialized in the U.S. and available within the Epic App Orchard. The technology targets patients that present to the Emergency Department and leverages artificial intelligence to triage and assess symptoms. The client is interested in a collaboration opportunity with an American health system to launch the solutions’s first clinical study in USA, which would be the first of its kind carried out in the U.S. Market. The technology was a NODE.Health Validation Competition category winner in 2018.

COVID Public Health Educational Tool

Supporting first phase of validation effort of a digital technology firm building a public health education and awareness solution to support the community during and after COVID. The solution is intended to alert citizens of local transmission trends and to provide feedback on health, hygiene, containment and mitigation efforts in support of the community returning to work.

This validation effort will review regulations and requirements associated with providing a public health, public facing solution designed to support the reintegration of citizens into the community and work force in a responsible, managed way. The effort will also look at the implications for responsibly connecting citizens with testing resources and in providing a platform for tracing and isolating the virus.


Completed phase one of NODE.Health’s validation process for an e-consent platform. The solution is a software platform that improves pre-and post-care education by using high-quality medical animations to explain treatment options, a survey to test for comprehension, and a video-based informed consent process to capture the doctor-patient conversation.

The platform will support patients in receiving the information they require prior to their respective procedures, especially those who are not able to attend multiple appointments due to social constraints.

Low-Cost Cardiac Output Monitor

Provided phase two support for a cardiac output monitoring tool, which is easier to operate and more cost-effective compared to current offerings in the market. This tool, which has been FDA approved, will enable patients to understand their cardiac issues in a more accurate manner, while reducing their long-term spending.

Neural Network Development for ECGs

Provided third phase support to help validate a new artificial intelligence platform called a ‘convolution neural network classifier’. The study evaluated the platform’s performance on various arrhythmias diagnosed on 12-lead ECGs and single-lead Holter monitors. The solution focused on identifying the correct arrhythmia at the time of a significant clinical event, including a cardiac arrest.

This tool aims to automate accurate ECG readings, especially among more sinister arrhythmias, to aid clinicians in their workup of patients lacking access to modern healthcare services.

AI CT Imaging

Provided phase one support for an artificial intelligence application related to non-contrast head/brain CT imaging for patients with head trauma or stroke symptoms. The technology provides a triage aid to prioritize and notify critical head CT scans, a TBI progress monitoring tool, and a reporting assistance mode that pre-populates radiologist templates. NODE.Health evaluated the critical end-points that should be prioritized as part of a validation effort.

This application can aid clinicians in rural and non-academic settings to better diagnose different types of head injuries. Using AI, the software can detect changes in radiological images to quicken the diagnostic process in patients with head injuries, which allows for treatment to begin sooner.

Non-Emergency Medical Transport

Supporting four phase multi-site validation effort of a digital technology firm that provides on-demand transportation services for patients. The solution is intending to demonstrate evidence that digital solutions can reduce no-show rates and improve transparency related to ride, quality and billing information in a HIPAA compliant platform.

Over 1/3 of all patients need transportation help, and missed appointments can lead to unnecessary progression of disease. This validation effort aims to review the impact of transport services on socially disadvantaged patients who have trouble attending their clinical appointments.